Connect with us

Health

Alzheimer’s-related dementia could be prevented by experimental drug, researchers say

Published

on

Alzheimer’s-related dementia could be prevented by experimental drug, researchers say

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

That’s according to a new study from Washington University School of Medicine in St. Louis, where researchers ran a clinical trial of people with rare genetic mutations that almost “guarantee” future Alzheimer’s development, according to a press release.

The study included 73 people in their 30s, 40s and 50s who have the mutation, which causes an overproduction of amyloid in the brain.

PARKINSON’S CASES COULD DOUBLE GLOBALLY BY 2050, STUDY REVEALS

Amyloid, a protein that builds up in the brain and can interfere with cognitive function, is one of the hallmarks of Alzheimer’s. 

Advertisement

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease. (iStock)

All participants had no (or very mild) cognitive decline, had a family history of Alzheimer’s, and were within 15 years before to 10 years after their expected age of developing symptoms, the release stated.

For 22 of the participants who received a drug called gantenerumab for eight years, their risk of developing symptoms was cut in half — from 100% to 50% — the researchers reported.

“What we do know is that it’s possible to at least delay the onset of the symptoms of Alzheimer’s disease and give people more years of healthy life.”

“There was no effect seen in those only treated for two to three years of treatment,” senior author Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, told Fox News Digital.

Advertisement

The findings were published in the journal The Lancet Neurology on March 19.

For 22 of the participants who received a drug called gantenerumab for eight years, their risk of developing symptoms was cut in half — from 100% to 50% — the researchers reported. (iStock)

Gantenerumab, a monoclonal antibody designed to target and remove amyloid plaques in the brain, was in development by Roche in Switzerland and its U.S. affiliate, Genentech.

Development was stopped in 2023, however, after Roche/Genentech’s own clinical trials found that the drug did not meet their “primary endpoint” for slowing cognitive decline in people with early symptomatic Alzheimer’s disease, according to the release.

HIGHER DEMENTIA RISK SEEN IN WOMEN WITH COMMON HEALTH ISSUE

Advertisement

“Everyone in this study was destined to develop Alzheimer’s disease and some of them haven’t yet,” said Bateman in the release.  

“We don’t yet know how long they will remain symptom-free – maybe a few years or maybe decades. In order to give them the best opportunity to stay cognitively normal, we have continued treatment with another anti-amyloid antibody in hopes they will never develop symptoms at all,” he went on.

The hope is that if late-onset Alzheimer’s trials have similar results, prevention methods could ultimately be available to the general population, according to the researchers. (iStock)

“What we do know is that it’s possible to at least delay the onset of the symptoms of Alzheimer’s disease and give people more years of healthy life.”

The hope is that if late-onset Alzheimer’s trials have similar results, prevention methods could ultimately be available to the general population, according to Bateman.

Advertisement

DEMENTIA RISK COULD INCREASE WITH LOW LEVELS OF ESSENTIAL VITAMIN

“I am highly optimistic now, as this could be the first clinical evidence of what will become preventions for people at risk of Alzheimer’s disease,” he said. “One day soon, we may be delaying the onset of Alzheimer’s disease for millions.”

Howard Fillit, MD, co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation in New York, noted that the study shows for the first time that early treatment to clear the plaques before symptoms arise can delay the onset of Alzheimer’s — “similar to how we treat and prevent other chronic diseases.”

Although gantenerumab is no longer being developed, researchers are evaluating other anti-amyloid drugs — such as remternetug, which is made by Eli Lilly — to determine whether they may prevent Alzheimer’s disease. (iStock)

“We’ve entered into a new era of Alzheimer’s research where we can not only modify the course of the disease, but where prevention is possible with therapeutic intervention,” Fillit, who was not involved in the study, told Fox News Digital.

Advertisement

Potential limitations and risks

There were several main limitations to the research, Bateman told Fox News Digital.

The number of people was limited due to the rarity of Alzheimer’s disease caused by mutations, the use of external controls, and the fact that the study started with lower doses, he said.

TWO ALZHEIMER’S DRUGS HELP PATIENTS LIVE INDEPENDENTLY AT HOME FOR LONGER PERIODS

“Many of the participants are still cognitively normal and near or past their expected age of onset even after more than eight years of treatment, so the effects could be larger or smaller with continued treatment and follow-up,” Bateman noted.

The researchers noted that anti-amyloid medications like gantenerumab have been shown to cause amyloid-related imaging abnormalities (ARIA).

Advertisement

Amyloid, a protein that builds up in the brain and can interfere with cognitive function, is one of the hallmarks of Alzheimer’s.  (iStock)

These appear on brain scans as “tiny spots of blood in the brain or localized swelling of the brain,” the release stated. 

The majority of these side effects do not cause symptoms and resolve without treatment, but in rare cases ARIA can cause serious medical issues or can even be fatal.

This most recent study showed that 30% of participants experienced ARIA, likely due to the higher doses of the drug. 

Although two participants had to stop using gantenerumab due to severe ARIA, there were no “life-threatening adverse events and no deaths,” the researchers noted. 

Advertisement

“Overall, the safety profile of gantenerumab in the extension was similar to that in the original trial and in other clinical trials of gantenerumab,” they stated.

More research needed, experts agree

Dr. Chris Vercammen, a board-certified internal medicine physician who specializes in geriatrics and palliative care, said that while these initial findings are “encouraging,” more research is needed on the effects of these medications.

“Large, randomized trials, including diverse populations and individuals with late-onset Alzheimer’s, are needed to validate these early results and determine the full potential of these treatments,” Vercammen, who is also medical director at Remo Health in California, told Fox News Digital. (He was not involved in the new study.)

   

“It’s important to note that this study’s design focused on high-risk individuals in the pre-clinical stage, and therefore does not provide sufficient data on the impact of these medications on later-stage Alzheimer’s.”

Advertisement

Fillit added that this new research opens the door for further exploration of treating preclinical Alzheimer’s.

Anti-amyloid medications like gantenerumab have been shown to cause amyloid-related imaging abnormalities (ARIA), which appear on brain scans as “tiny spots of blood in the brain or localized swelling of the brain.” (iStock)

“We look forward to seeing the longitudinal data as well as further studies around this approach,” he told Fox News Digital.

“These efforts bring us one step closer to our ultimate goal of preventing the disease before it begins.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

Although gantenerumab is no longer being developed, researchers are evaluating other anti-amyloid drugs — such as remternetug, which is made by Eli Lilly — to determine whether they may prevent Alzheimer’s disease.

“These efforts bring us one step closer to our ultimate goal of preventing the disease before it begins.”

“These rare families with mutations may wish to participate in ongoing trials,” Bateman told Fox News Digital.  

“The older general population might be interested to know that there are ongoing trials in people with amyloid plaques to test this approach to determine if Alzheimer’s symptoms could be prevented.”

For more Health articles, visit www.foxnews.com/health

Advertisement

The study was funded primarily by the Alzheimer’s Association, GHR Foundation and the National Institutes of Health (NIH).

Fox News Digital reached out to Roche/Genentech for comment.

Advertisement

Health

Brain Health Challenge: Try a Brain Teaser

Published

on

Brain Health Challenge: Try a Brain Teaser

Welcome back! For Day 4 of the challenge, let’s do a short and fun activity based around a concept called cognitive reserve.

Decades of research show that people who have more years of education, more cognitively demanding jobs or more mentally stimulating hobbies all tend to have a reduced risk of cognitive impairment as they get older.

Advertisement

Experts think this is partly thanks to cognitive reserve: Basically, the more brain power you’ve built up over the years, the more you can stand to lose before you experience impairment. Researchers still don’t agree on how to measure cognitive reserve, but one theory is that better connections between different brain regions corresponds with more cognitive reserve.

To build up these connections, you need to stimulate your brain, said Dr. Joel Salinas, a neurologist at NYU Langone Health and the founder and chief medical officer of the telehealth platform Isaac Health. To do that, try an activity that is “challenging enough that it requires some effort but not so challenging that you don’t want to do it anymore,” he said.

Advertisement

Speaking a second language has been shown to be good for cognition, as has playing a musical instrument, visiting a museum and doing handicrafts like knitting or quilting. Reading is considered a mentally stimulating hobby, and experts say you’ll get an even bigger benefit if you join a book club to make it social. Listen to a podcast to learn something new, or, better yet, attend a lecture in person at a local college or community center, said Dr. Zaldy Tan, the director of the Memory and Healthy Aging Program at Cedars-Sinai. That adds a social component, plus the extra challenge of having to navigate your way there, he said.

A few studies have found that playing board games like chess can be good for your brain; the same goes for doing crossword puzzles. It’s possible that other types of puzzles, like those you find in brain teaser books or from New York Times Games, can also offer a cognitive benefit.

But there’s a catch: To get the best brain workout, the activity should not only be challenging but also new. If you do “Wordle every day, it’s like well, then you’re very, very good at Wordle, and the Wordle part of your brain has grown to be fantastic,” said Dr. Linda Selwa, a clinical professor of neurology at the University of Michigan Medical School. “But the rest of your mind might still need work.”

Advertisement

So play a game you’re not used to playing, Dr. Selwa said. “The novelty seems to be what’s driving brain remodeling and growth.”

Today, we want you to push yourself out of your cognitive comfort zone. Check out an online lecture or visit a museum with your challenge partner. Or try your hand at a new game, below. Share what novel thing you did today in the comments, and I’ll see you tomorrow for Day 5.

Advertisement
Continue Reading

Health

Popular intermittent fasting diets may not deliver the health benefits many expect

Published

on

Popular intermittent fasting diets may not deliver the health benefits many expect

NEWYou can now listen to Fox News articles!

Time-restricted eating has gained popularity in recent years, but a recent study suggests that intermittent fasting — while effective for weight loss — might not live up to the hype in terms of wider benefits.

The small German study found that participants who were placed on two different time-restricted eating schedules lost weight, but experienced no improvement in blood glucose, blood pressure, cholesterol or other key cardiometabolic markers.

The participants included 31 overweight or obese women. One group ate between 8 a.m. and 4 p.m. and the other group ate between 1 p.m. and 9 p.m. for a two-week period, while maintaining their typical caloric intake, according to a press release.

EATING FOR PLEASURE MAY BOOST HEALTH, SAY EXPERTS — HERE ARE 6 FOODS TO TRY

Advertisement

The findings, which were published in the journal Science Translational Medicine, suggest that the widely touted cardiometabolic benefits of intermittent fasting may be a result of eating fewer calories rather than meal timing, the researchers say.

The participants also showed a shift in their circadian rhythms (sleep/wake cycles) when they were placed on the time-restricted eating schedules, but the associated health impacts are not known.

A recent study suggests that intermittent fasting — while effective for weight loss — might not live up to the hype in terms of wider benefits. (iStock)

The study did have some limitations. Some researchers have cast doubt on the significance of the study due to its small size.

“It is severely underpowered to detect any difference, considering how gentle the intervention is,” Dr. Dr. Jason Fung, a Canadian physician, author and researcher, told Fox News Digital. He also noted that the participants were fasting for 16 hours a day instead of the normal 12 to 14 hours.

Advertisement

THIS WEIGHT LOSS PLAN PERFORMS BETTER THAN TRADITIONAL DIETING, STUDY FINDS

Lauren Harris-Pincus, a registered dietitian nutritionist in New Jersey, agreed that the findings could be due to the fact that there was no intentional caloric restriction, and reiterated that the sample size is “quite small.” 

“As a registered dietitian, I only recommend time-restricted eating when it is carefully planned and shifted earlier within the day,” Harris-Pincus, who was not involved in the study, told Fox News Digital.

One group in the study ate between 8 a.m. and 4 p.m. and the other group ate between 1 p.m. and 9 p.m. for a two-week period, while maintaining their typical caloric intake. (iStock)

“Only one in 10 Americans consumes the recommended number of fruits and veggies, and 93% miss the mark on fiber goals. Restricting an eating window necessitates more careful meal planning to ensure adequate intake of macro- and micronutrients.”

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

The expert also cautioned that skipping breakfast to enable a later eating window may result in lower intake of the “nutrients of concern” in the American diet, including calcium, potassium, fiber and vitamin D. 

Looking ahead, the researchers said more studies are needed to explore the effects of time-restricted eating over longer time periods. It also remains to be seen how the combination of caloric restriction and time-restricted eating may affect outcomes. Future research could also explore how different populations may respond.

“I only recommend time-restricted eating when it is carefully planned and shifted earlier within the day.”

Dr. Daryl Gioffre, a gut health specialist and celebrity nutritionist in New York, noted that the study didn’t account for critical factors like chronic stress, sleep quality, medications, hormone status and baseline metabolic health.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“All of these can significantly blunt fat loss and cardiometabolic improvements,” Gioffre, who also was not involved in the research, told Fox News Digital.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“Cortisol, the body’s primary stress hormone, is naturally highest in the morning, which overlaps with one of the fasting windows studied,” he went on. “If stress is elevated, cortisol alone can block fat burning, disrupt blood sugar regulation, and mask cardiovascular improvements, regardless of calorie intake or eating window.”

Growing research shows intermittent fasting — when done correctly and sustained over time — can improve insulin regulation, reduce inflammation, support fat loss and contribute to better cardiovascular health, an expert said. (iStock)

Advertisement

Gioffre did agree, however, that growing research shows intermittent fasting — when done correctly and sustained over time — can improve insulin regulation, reduce inflammation, support fat loss and contribute to better cardiovascular health.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“These are outcomes that simply cannot be captured in a short, stress-blind study like this,” he added.

Fox News Digital reached out to the researchers for comment.

Advertisement
Continue Reading

Health

Brain Health Challenge: Workouts to Strengthen Your Brain

Published

on

Brain Health Challenge: Workouts to Strengthen Your Brain

Today, you’re going to do perhaps the single best thing for your brain.

When I asked neurologists about their top behaviors for brain health, they all stressed the importance of physical activity.

Advertisement

“Exercise is top, No. 1, when we’re thinking about the biggest bang for your buck,” said Dr. Gregg Day, a neurologist at the Mayo Clinic.

Numerous studies have shown that people who exercise regularly tend to perform better on attention, memory and executive functioning tests. There can be a small cognitive boost immediately after a workout, and the effects are sustained if people exercise consistently. And while staying active can’t guarantee you won’t develop dementia, over the long term, it is associated with a lower risk of it.

Advertisement

Researchers think that moving your muscles benefits your brain in part because of special signaling molecules called exerkines. During and after a workout, your muscles, fat and other organs release these molecules into the bloodstream, some of which make their way up to the brain. There, those exerkines go to work, helping to facilitate the growth of new connections between neurons, the repair of brain cells and, possibly, the birth of new neurons.

Exercise also appears to improve blood flow in the brain. That ramps up the delivery of good things to brain cells, like oxygen, glucose and those amazing exerkines. And it helps remove more bad things, namely toxic proteins, like amyloid, that can build up and damage brain cells, increasing the risk for Alzheimer’s.

All of the changes brought on by exercise are “essentially allowing your brain to age more slowly than if you’re physically inactive,” said Kirk Erickson, the chair of neuroscience at the AdventHealth Research Institute.

Advertisement

The benefits are particularly pronounced in the hippocampus, a region critical for learning and memory. In older adults, the hippocampus shrinks 1 to 2 percent a year, and it is one of the main areas affected by Alzheimer’s. Researchers think physical activity helps to offset some of that loss.

The best exercise you can do for your brain is the one you’ll do consistently, so find something that you enjoy and that fits easily into your life.

Advertisement

Walking is one option; two neurologists I spoke to said they got their exercise in by walking at least part of the way to their offices. Recent research suggests that just a few thousand steps a day can reduce the risk of dementia. It’s important to get your heart rate up, though, so “walk as though you’re trying to get somewhere on time,” said Dr. Linda Selwa, a clinical professor of neurology at the University of Michigan Medical School.

Or you could try swimming, cycling, Pilates, weight lifting, yoga, pickleball, dancing, gardening — any type of physical exertion can be beneficial.

If the thought of working out feels like a drag, try pairing it with something else you enjoy doing, like listening to an audiobook. This is a trick that Katherine Milkman, a professor who studies habits at The Wharton School of the University of Pennsylvania, calls “temptation bundling.”

Advertisement

For Day 3, we’re asking you to spend at least 20 minutes exercising for your brain. Go for a walk with your accountability partner if they’re nearby. (If not, call them and do a walk-and-talk.) Or let us find you a new workout to try, using the tool below. As usual, we can all meet in the comments to catch up and check in.

Advertisement
Continue Reading
Advertisement

Trending